Murphy & Mullick Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.5K Sell
1,545
-485
-24% -$10K 0.02% 366
2026
Q2
$39.6K Buy
2,030
+15
+0.7% +$298 0.02% 334
2026
Q1
$38.8K Buy
2,015
+7
+0.3% +$138 0.03% 315
2025
Q4
$38K Buy
2,008
+1,008
+101% +$18.7K 0.03% 331
2025
Q3
$17.5K Hold
1,000
– – 0.01% 407
2025
Q2
$18.4K Hold
1,000
– – 0.02% 382
2025
Q1
$17.5K Hold
1,000
– – 0.02% 379
2024
Q4
$17.3K Buy
+1,000
New +$18.3K 0.02% 373

Other funds holding SBRA

Murphy & Mullick Capital Management's SBRA Position: Q3 2026 in Review

Murphy & Mullick Capital Management reduced its Sabra Healthcare REIT (SBRA) stake by 24% in Q3 2026, selling an estimated $10K and leaving 1,545 shares worth $30.5K. The position accounts for 0.02% of the portfolio, ranked #366.

Murphy & Mullick Capital Management first reported a position in SBRA in Q4 2024 and has held it in 8 quarters since. The position peaked at $39.6K in Q2 2026. 453 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • Murphy & Mullick Capital Management held 1,545 shares of Sabra Healthcare REIT worth $30.5K as of Q3 2026.
  • Murphy & Mullick Capital Management sold 485 Sabra Healthcare REIT shares in Q3 2026, an estimated $10K.
  • Sabra Healthcare REIT made up 0.02% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #366 holding.
  • Murphy & Mullick Capital Management first reported a position in Sabra Healthcare REIT in Q4 2024 and has held it in 8 quarters since.
  • Murphy & Mullick Capital Management's Sabra Healthcare REIT position peaked at $39.6K in Q2 2026.
  • 453 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.